Alkem Laboratories

Nomura holds Nifty target at 26,140 but shakes up portfolio — Swiggy, Titan and 2 more added; Full list inside

Nomura keeps its Nifty target at 26,140, signaling limited upside. The firm pivots toward domestic consumption and pharma, adding Swiggy,…

Updated: October 21, 2025 12:07 IST

From KEC International, RVNL to Brigade Enterprises – Here are 7 stocks to watch today

Track top stocks like KEC International, RVNL, Brigade Enterprises, and more as corporate moves could impact markets today—discover the latest…

September 23, 2025 06:35 IST

2 Healthcare Stocks Flashing Bullish Signals. Add them to your watchlist?

While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…

Updated: September 1, 2025 09:05 IST

stocks to watch, stock in news, stocks in news, stocks to know

Stocks to watch today: From Bharti Airtel, JSW Steel to Godrej Industries – Here’s a list of 8 stocks in focus today

Watch telecom, energy, pharma stocks today; key Q4 results and market cues to guide investors. Explore the highlighted stocks now!

May 16, 2025 06:29 IST

Alkem Labs launches generic formulation of Boehringer’s diabetes drug in India

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.

March 12, 2025 11:35 IST

Nuvama cuts target price on Alkem Lab: Find out why?

Nuvama cuts Alkem Lab’s target price by 3.5% amid slow acute business; read more for insights on future projections.

February 10, 2025 10:06 IST

MSCI rejig today: HDFC Bank, Voltas, BSE, 10 other stocks likely to see over $2 billion inflow; Adani Group stocks out of MSCI

The MSCI rebalancing takes effect today, with Indian equities set to attract $1.7 billion inflows. HDFC Bank and five other…

November 25, 2024 12:39 IST

Q2FY25: Alkem Labs’ profit rises by 11% YoY to Rs 689 crore; revenue falls marginally

As per IQVIA (SSA) data, for Q2FY25, the company registered a growth of 6.3 percent YoY vs. the Indian Pharmaceutical…

November 13, 2024 14:18 IST

Alkem Laboratories enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India

Alkem Labs enters into licensing agreement with Sonnet BioTherapeutics for its diabetic peripheral neuropathy drug in India

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a major one.

October 11, 2024 10:46 IST

substandard drugs, CDSCO report, Paracetamol, Pantoprazole, drug quality, pharmaceutical safety, healthcare regulations, patient safety, medicine quality control, Indian pharmaceuticals

CDSCO flags 53 popular medicines of poor quality; Alkem labs denies claims of Pan-D, Clavam 625 being not-of-standard quality

Alkem has already submitted a response to the CSDCO, along with the assessment report which confirmed that samples collected by…

September 27, 2024 18:10 IST

Alkem Laboratories Q1 Results: Total revenue up 2.2% y-o-y, net profit up 90%

Alkem outperformed the IPM in antidiabetic, Neuro/CNS, gastro-intestinal, dermatology, and VMN therapies, with improved rankings in Neuro/CNS and Respiratory therapies.

Updated: August 9, 2024 17:33 IST

Welspun Corp, EPIC, Aramco, order, order value, steel pipe

Alkem Laboratories Q4 Results: Profit jumps multi-fold to Rs 293.56 crore, final dividend of Rs 5 announced

Alkem Laboratories posted revenue from operations at Rs 2935.82 crore, marginally higher as compared to Rs 2902.60 crore recorded during…

May 29, 2024 15:09 IST

Alkem Laboratories, tax evasion, income tax department, Sikkim manufacturing unit

Alkem Laboratories denies media reports alleging tax evasion of over Rs 1000 cr, calls it ‘factually incorrect’

“The company asserts its commitment to compliance and transparency, having fully cooperated with the Income Tax Department officials during their…

February 26, 2024 14:50 IST

Alkem Laboratories shares after q2 results

Alkem Laboratories posts buoyant growth in Q2; Should you buy, hold or sell the stock?

Shares of Alkem Laboratories have delivered remarkable returns to investors, with a 13% gain in the last five days, 19%…

November 8, 2023 14:55 IST

Alkem Laboratories, Biosergen, fungal infection, anti-infectives, healthcare news, pharma news,

Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections

Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient…

September 25, 2023 14:34 IST

Alkem Laboratories, Q4FY23 results, quarter results, profit, revenue, EBITDA, dividend, pharmaceuticals

Alkem Laboratories Q4FY23 Results: Profit tumbles 34% to Rs 71 crore, revenue up 16.9% on-year

Alkem Laboratories posted revenue from operations for the fiscal fourth quarter at Rs 2902.60 crore, up 16.9 per cent from…

May 19, 2023 14:37 IST

Alkem laboratories, StemOne, Stempeutics, Knee Osteoarthritis, health news, pharma news,

Alkem Labs launches off-the-shelf cell therapy StemOne for knee joint diseases

Knee Osteoarthritis is one of the most common debilitating diseases experienced within an ageing population and constitutes an urgent medical…

September 19, 2022 13:39 IST

Institutional investors dissent over FSN E-Commerce’s five resolutions

IDFC’s resolution to appoint an independent director (99.99%) was also approved during the week.

February 15, 2022 01:01 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Big Aadhaar update from November 2025: No document upload needed — UIDAI to verify details automatically

F-1 visa denied for applicant after single question at US Consulate

India agrees to cut Russian oil imports, US may slash tariffs to 15% under new trade deal: Report

India agrees to cut Russian oil purchase, open agriculture- Trump may reduce tariff to 15%: Report

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Credit cover scheme for MSMEs to be compact, likely by Q4

India News19 min ago

The government will launch a credit guarantee scheme for MSMEs in the next quarter to assist them in dealing with US tariffs and other challenges. The scheme will cover 100% of loans given by lenders, excluding deliberate defaulters. The ECLGS has been successful in improving asset quality and reducing loan defaults. The formalization of MSMEs has also aided banks in accessing reliable data.

View all shorts